Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ · Healthcare
Vanda Pharmaceuticals Inc. Net Income 2009–2025
Vanda Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2009 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Vanda Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was -48.6 M, a 64.67% increase year-over-year.
- Vanda Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was -127.9 M, a 823.07% increase year-over-year.
- Vanda Pharmaceuticals Inc. annual net income for 2025 was -220.5 M, a 1066.53% increase from 2024.
- Vanda Pharmaceuticals Inc. annual net income for 2024 was -18.9 M, a 853.29% decrease from 2023.
- Vanda Pharmaceuticals Inc. annual net income for 2023 was 2.5 M, a 60.02% decrease from 2022.
- Vanda Pharmaceuticals Inc. annual net income for 2022 was 6.3 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Vanda Pharmaceuticals Inc. Net Income — FAQ
Vanda Pharmaceuticals Inc. (VNDA) net income over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Vanda Pharmaceuticals Inc.'s net income?
Vanda Pharmaceuticals Inc. (VNDA) reported net income of -$220M for fiscal 2025.
Where can I see VNDA's net income history?
The chart and table above show Vanda Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.